Market Overview:
The global pet specialty drugs market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing trend of pet ownership, rising awareness about animal health and growing demand for premium quality pet products. Additionally, the increasing prevalence of zoonotic diseases is also propelling the growth of this market. On the basis of type, antibiotics are expected to account for a major share in the global pet specialty drugs market during the forecast period. This can be attributed to their high usage rates for treating various infections in pets. Anti-inflammatory drugs are also anticipated to witness significant growth during the forecast period owing to their wide usage for treating various inflammatory conditions in pets. On basis on application, dogs are estimated ot account for a major share in terms revenue generated by global pet specialty drug market during 2018-2030 followed by cats.
Product Definition:
A pet specialty drug is a medication that is specifically designed to treat a certain type of animal. These drugs are often developed with the help of veterinarians and are used to treat conditions that are unique to pets. The importance of pet specialty drugs lies in their ability to provide relief for specific ailments that pets experience, which can include conditions such as cancer, diabetes, and arthritis.
Antibiotics:
Antibiotics are types of antimicrobial drugs used to treat bacterial infections. They may be used on animals as well as people. Antimicrobials are mainly categorized into two groups, first, there are the antibiotics derived from natural products such as penicillin and cephalosporin; and second, synthetic (man-made) antibiotics such as tetracycline, doxycycline etc.
Anti-inflammatory Drugs:
Anti-inflammatory drugs are used to reduce the inflammation of any body part or organ. The most common symptoms that cause an inflammatory response are redness, swelling, and heat. Inflammation can be caused by a number of factors such as infections, autoimmune diseases, genetic disorders among others. Some of the medications used for inflammatory conditions include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids oral medications like prednisone and other injections like methotrexate.
Application Insights:
The other application segment includes fish drugs, bird drugs and pet medicines. The demand for these products is generally higher in the urban areas as compared to rural areas. Urbanization plays a major role in increasing the purchasing power of money and thus increases the spending on healthcare. Moreover, an increase in disposable income enables people to spend more on healthcare without affecting their standard of living too much.
Dogs held approximately 37% of revenue share within this segment globallyPet specialty drugs market by region 2016 (%)and this trend is expected to continue over next six years due largelyto growing popularity among dog owners owingto benefits associated with treatment such as improved vision at night time.
Regional Analysis:
North America dominated the global pet speciality drugs market in 2017. The rising incidence of chronic diseases and increasing pet ownership are some of the major factors contributing to the growth of this regional market. According to a study conducted by Global Pet Market Size, Value & Trends Report, Inc., in U.S., around 68%of American households owned at least one dog while 58% had a cat in 2016’s survey. Moreover, dogs and cats are considered as family members by most Americans which increases their expenditure on veterinary health care products such as vaccines and medicines for treatment purposes (Parasiticides).
Growth Factors:
- Increasing demand for premium pet food and products
- Rising trend of pet humanization
- Proliferation of e-commerce platforms for pet supplies
- Growing popularity of veterinary clinics and hospitals
- Emergence of new product categories
Scope Of The Report
Report Attributes
Report Details
Report Title
Pet Speciality Drugs Market Research Report
By Type
Antibiotics, Anti-inflammatory Drugs, Vaccines, Parasiticides, Skin Care Products, Others
By Application
Dogs, Cats, Other
By Companies
Zoetis, Merck, Bayer, Elanco, Boehringer Ingelheim, Ceva Sante Animale, Vetoquinol, Virbac, Wedgewood Pharmacy, Lee Silsby Compounding Pharmacy, Golden Gate Veterinary Compounding Pharmacy, CAHIC, Ringpu
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
127
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global Pet Speciality Drugs Market Report Segments:
The global Pet Speciality Drugs market is segmented on the basis of:
Types
Antibiotics, Anti-inflammatory Drugs, Vaccines, Parasiticides, Skin Care Products, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dogs, Cats, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Merck
- Bayer
- Elanco
- Boehringer Ingelheim
- Ceva Sante Animale
- Vetoquinol
- Virbac
- Wedgewood Pharmacy
- Lee Silsby Compounding Pharmacy
- Golden Gate Veterinary Compounding Pharmacy
- CAHIC
- Ringpu
Highlights of The Pet Speciality Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Anti-inflammatory Drugs
- Vaccines
- Parasiticides
- Skin Care Products
- Others
- By Application:
- Dogs
- Cats
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pet Speciality Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pet specialty drugs are medications specifically designed for pets. These medications may be prescribed by a veterinarian, or they may be available over the counter. Pet specialty drugs can help treat a variety of conditions, including allergies, arthritis, cancer, and more.
Some of the major companies in the pet speciality drugs market are Zoetis, Merck, Bayer, Elanco, Boehringer Ingelheim, Ceva Sante Animale, Vetoquinol, Virbac, Wedgewood Pharmacy, Lee Silsby Compounding Pharmacy, Golden Gate Veterinary Compounding Pharmacy, CAHIC, Ringpu.
The pet speciality drugs market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pet Speciality Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pet Speciality Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pet Speciality Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pet Speciality Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pet Speciality Drugs Market Size & Forecast, 2018-2028
4.5.1 Pet Speciality Drugs Market Size and Y-o-Y Growth
4.5.2 Pet Speciality Drugs Market Absolute $ Opportunity
Chapter 5 Global Pet Speciality Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pet Speciality Drugs Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Anti-inflammatory Drugs
5.2.3 Vaccines
5.2.4 Parasiticides
5.2.5 Skin Care Products
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pet Speciality Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pet Speciality Drugs Market Size Forecast by Applications
6.2.1 Dogs
6.2.2 Cats
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pet Speciality Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pet Speciality Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pet Speciality Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Pet Speciality Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pet Speciality Drugs Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Anti-inflammatory Drugs
9.6.3 Vaccines
9.6.4 Parasiticides
9.6.5 Skin Care Products
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pet Speciality Drugs Market Size Forecast by Applications
9.10.1 Dogs
9.10.2 Cats
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pet Speciality Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Pet Speciality Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pet Speciality Drugs Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Anti-inflammatory Drugs
10.6.3 Vaccines
10.6.4 Parasiticides
10.6.5 Skin Care Products
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pet Speciality Drugs Market Size Forecast by Applications
10.10.1 Dogs
10.10.2 Cats
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pet Speciality Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pet Speciality Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pet Speciality Drugs Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Anti-inflammatory Drugs
11.6.3 Vaccines
11.6.4 Parasiticides
11.6.5 Skin Care Products
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pet Speciality Drugs Market Size Forecast by Applications
11.10.1 Dogs
11.10.2 Cats
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pet Speciality Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Pet Speciality Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pet Speciality Drugs Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Anti-inflammatory Drugs
12.6.3 Vaccines
12.6.4 Parasiticides
12.6.5 Skin Care Products
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pet Speciality Drugs Market Size Forecast by Applications
12.10.1 Dogs
12.10.2 Cats
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pet Speciality Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pet Speciality Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pet Speciality Drugs Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Anti-inflammatory Drugs
13.6.3 Vaccines
13.6.4 Parasiticides
13.6.5 Skin Care Products
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pet Speciality Drugs Market Size Forecast by Applications
13.10.1 Dogs
13.10.2 Cats
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pet Speciality Drugs Market: Competitive Dashboard
14.2 Global Pet Speciality Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis
14.3.2 Merck
14.3.3 Bayer
14.3.4 Elanco
14.3.5 Boehringer Ingelheim
14.3.6 Ceva Sante Animale
14.3.7 Vetoquinol
14.3.8 Virbac
14.3.9 Wedgewood Pharmacy
14.3.10 Lee Silsby Compounding Pharmacy
14.3.11 Golden Gate Veterinary Compounding Pharmacy
14.3.12 CAHIC
14.3.13 Ringpu
